Cancer Patients Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Cancer Patients clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 52 trials

Recruiting
Phase 3

64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer

Prostate CancerCryotherapyProstate Cancer Recurrent+3 more
Clarity Pharmaceuticals Ltd220 enrolled28 locationsNCT06970847
Recruiting

SpaceOAR Post-Market Registry Study

Prostate Cancer Patients Treated by Radiotherapy
Sheffield Teaching Hospitals NHS Foundation Trust320 enrolled8 locationsNCT07300631
Recruiting
Phase 2

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Prostate Cancer (Adenocarcinoma)Prostate Cancer Patients Treated by Radiotherapy
Candel Therapeutics, Inc.45 enrolled7 locationsNCT07332000
Recruiting
Not Applicable

Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial

Prostate Cancer Patients Treated by Radiotherapy
Hong Kong Sanatorium & Hospital35 enrolled1 locationNCT07130682
Recruiting
Phase 1

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

Metastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Castration-resistant Prostate CancermCRPC (Metastatic Castration-resistant Prostate Cancer)+2 more
K36 Therapeutics, Inc.144 enrolled13 locationsNCT07103018
Recruiting
Phase 1

Trial of pTVG-HP+Nivo+Targeted Ablation of Resistant Lesions in Non-Castrate RecurrentOMPC

Prostate Cancer PatientsRecurrent Prostate CancerOligometastatic Prostate Cancer (OMPC)+1 more
University of Wisconsin, Madison14 enrolled1 locationNCT07090148
Recruiting
Phase 2

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer(CONTROL-01)

Rectal Cancer Patients
The Affiliated Hospital of Qingdao University35 enrolled1 locationNCT06647680
Recruiting
Not Applicable

A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers

Cancer PatientsCare Givers
Memorial Sloan Kettering Cancer Center60 enrolled7 locationsNCT06305741
Recruiting

Pain Evaluation Across Robotic and Laparoscopic Surgery for Colorectal Procedures

Minimally Invasive Surgical ProceduresColon Cancer Patients
Hospital Central de la Defensa Gómez Ulla80 enrolled1 locationNCT07431892
Recruiting
Phase 2

Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer

Prostate CancerProstate Cancer Patients Treated by Radiotherapy
Medical University of South Carolina46 enrolled1 locationNCT07325721
Recruiting
Not Applicable

Addition of Focal Boost to Primary Radiotherapy for Prostate Cancer in 12 or 20 Fractions

Locally Advanced Prostate CancerProstate Cancer Patients Undergoing External Radiation and Seed ImplantationHigh Risk Localised Prostate Carcinoma+1 more
Rigshospitalet, Denmark1,016 enrolled3 locationsNCT07343349
Recruiting
Phase 2Phase 3

A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients

Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine300 enrolled2 locationsNCT03258320
Recruiting
Not Applicable

Irreversible Electroporation for Recurrent or Metastatic Cervical Lymph Node Metastases From Thyroid Cancer: A Prospective Multicenter Single-Arm Study

Lymph Node MetastasisThyroid Cancer Patients
Tian'an Jiang85 enrolled1 locationNCT07328243
Recruiting
Phase 1

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

EGFR Mutation Positive Non-small Cell Lung CancerEGFR Mutated Non-small Cell Lung Cancer Patients
Nuvectis Pharma, Inc.18 enrolled3 locationsNCT07315113
Recruiting
Not Applicable

Limited Versus Extended Lymph Node Dissection During Radical Prostatectomy in Patients With Localized or Locally Advanced Prostate Cancer

Prostate Cancer Patients Undergoing Radical Prostatectomy
N.N. Alexandrov National Cancer Centre800 enrolled1 locationNCT07308990
Recruiting
Not Applicable

Mindfulness-Oriented Respiratory Distress Symptom Intervention for Lung Cancer

Symptom ClusterBreathlessnessCoughing+3 more
The Hong Kong Polytechnic University50 enrolled1 locationNCT07281300
Recruiting
Phase 2

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

HER2-negative Breast Cancer Patients With Brain Metastases
Biostar Pharma, Inc.120 enrolled17 locationsNCT06764940
Recruiting
Phase 2

Randomized Trial Comparing Standard of Care Versus Immune- Based Combination in Relapsed Stage III Non-small-cell Lung Cancer (NSCLC) Pretreated With Chemoradiotherapy and Durvalumab

Non-small-cell Lung Cancer Patients
Fondazione Ricerca Traslazionale176 enrolled1 locationNCT05568212
Recruiting

AI-Assisted Detection and Staging of Gastric Cancer Using Contrast-Enhanced CT

Gastric Cancer StageGastric Cancer Patients Undergoing Gastrectomy
The First Affiliated Hospital with Nanjing Medical University8,000 enrolled1 locationNCT07250347
Recruiting
Not Applicable

Cancer Survivors Program

Breast Cancer PatientsProstate Cancer Patients
Masaryk Memorial Cancer Institute200 enrolled1 locationNCT07253987